# FDA recall D-318-2013

> **L. Perrigo Co.** · Class III · drug recall initiated 2013-03-12.

## Product

Liothyronine Sodium Tablets, USP,  5 mcg Rx ONLY, 100 count bottle, Distributed by: Paddock Laboratories, Inc.,  Minneapolis, MN 55427,  NDC 0574-0220-01,

## Reason for recall

Failed Impurities/Degradation Specifications: 3 month stability testing.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-318-2013
- **Recalling firm:** L. Perrigo Co.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-03-12
- **Report date:** 2013-05-15
- **Termination date:** 2013-07-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Allegan, MI, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-318-2013

## Citation

> AI Analytics. FDA recall D-318-2013. Retrieved 2026-06-08 from https://api.ai-analytics.org/recall/D-318-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*